4//SEC Filing
ADAPT I Ltd. 4
Accession 0001104659-25-061805
CIK 0002019410other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 6:31 PM ET
Size
10.5 KB
Accession
0001104659-25-061805
Insider Transaction Report
Form 4
ADAPT I Ltd.
10% Owner
Transactions
- Conversion
Series A Preferred Stock
2025-06-20−14,000,000→ 0 total(indirect: See Footnotes)Exercise: $0.00→ Common Stock (3,500,003 underlying) - Conversion
Common Stock
2025-06-20+3,500,003→ 16,943,232 total(indirect: See Footnotes)
Carisome I, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2025-06-20+3,500,003→ 16,943,232 total(indirect: See Footnotes) - Conversion
Series A Preferred Stock
2025-06-20−14,000,000→ 0 total(indirect: See Footnotes)Exercise: $0.00→ Common Stock (3,500,003 underlying)
Footnotes (3)
- [F1]Each share of preferred stock automatically converted into 0.25 shares of Common Stock of the Issuer upon the closing of the initial public offering of the Issuer's Common Stock.
- [F2]The Common Stock reported herein includes 8,528,805 shares of Common Stock held of record by ADAPT I Ltd. and 8,414,427 shares of Common Stock held of record by Carisome I, L.P. Two family trusts are separately the general partner of ADAPT I Ltd. and the managing general partner of Carisome I, L.P., respectively. David D. Halbert is the trustee of each of the two family trusts, and in such capacities, has voting and investment power with respect to the shares held of record by each of the foregoing entities. Mr. Halbert disclaims beneficial ownership except to the extent of his pecuniary interest therein.
- [F3]The preferred stock reported herein includes 3,500,003 shares of Common Stock underlying Series A Preferred Stock held of record by ADAPT I Ltd..
Documents
Issuer
Caris Life Sciences, Inc.
CIK 0002019410
Entity typeother
IncorporatedTX
Related Parties
1- filerCIK 0002072411
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 6:31 PM ET
- Size
- 10.5 KB